This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents …

NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more

~Estimated

~$10 – $8,750

IDEAYA BiosciencesNCT07277413

Phase 1

A Phase 1, First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC028 in Participants With Advanced Solid Tumors

The goal of this clinical trial is to characterize the safety, tolerability, dose-limiting toxicities (DLT), and maximum tolerated dose (MTD) or maximum admini…

Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more

~Estimated

~$10 – $7,500

MacroGenicsNCT06723236